MedPath

Spanish Randomized Clinical Trial on Sindax

Phase 1
Conditions
Patients who have preoperatively severe left ventricular dysfunction (LVEF = 35%) and will be scheuled for cardiac surgery on cardiopulmonary bypass.
Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
Registration Number
EUCTR2019-001756-19-ES
Lead Sponsor
María de los Ángeles Tena Pajuelo (Investigador independiente)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
All
Target Recruitment
300
Inclusion Criteria

1. Patients 18 years of age or older.
2. Documented ejection fraction of the left ventricle = 35% measured by
echocardiogram within 7 days prior to surgery.
3. Patients scheduled to undergo one of the following cardiac surgery with
extracorporeal circulation of:

1) surgery on the aortic valve, or

2) myocardial revascularization surgery due to ischemic heart disease or

3) the two previous procedures combined.

4. Patients who have signed the informed consent.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 300
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 300

Exclusion Criteria

1. Previous administration of Levosimendan
2. Emergency operation
3. Previous or pending renal or liver transplantation.
4. Liver cirrhosis: Child C. In the case of Child B, contact the Coordinating Center.
5. Any degree of preoperative right ventricular failure
6. Preoperative creatinine> 2 mg / dl
7. Valvulopathy that is not aortic.
8. Renal impairment with dialysis (or creatinine clearance <30ml / min).
9. Hemodynamic instability (need for inotropics, unstable angina, acute AMI,
use of counterpulsation balloon).
10. Reoperated.
11. Hypersensitivity to levosimendan or any of the excipients.
12. Severe hypotension and tachycardia
13. History of Torsades de Pointes.
14. Pregnancy or Lactation.

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath